Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes

AIDS

Volumn 13, Issue 17, 1999, Pages 2331-2341

  Kohleisen, Birgit ^a,b,c,d,e   Shumay, Elena ^a   Sutter, Gerd ^a   Foerster, Reinhold ^a   Brack Werner, Ruth ^a   Nuesse, Michael ^a   Erfle, Volker ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Bavarian Nordic GmbH   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d CSF Flow Cytometry Group   (Germany)

^e Institute of Molecular Virology   (Germany)

Author keywords

Astrocytes; Astrogliosis; HIV 1; Nef; Neuropathogenesis

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; NEF PROTEIN;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL SELECTION; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; ASTROCYTES; BASE SEQUENCE; CELL DIVISION; CELL LINE; DNA PRIMERS; GENE EXPRESSION; GENE PRODUCTS, NEF; GENES, NEF; GLIAL FIBRILLARY ACIDIC PROTEIN; HIV INFECTIONS; HIV-1; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VIRULENCE;

EID: 0032785802     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199912030-00004     Document Type: Article

References (70)

1. Epstein LC, Goudsmit J, Paul DA, et al. HIV expression in the cerehrospinal fluid of children with progressive encephalopathy. Ann Neurol 1987, 21:396-401.
2. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissue of patients with neurological syndromes related to the acquired immunodeficiency syndrome. N EnglJMed 1985, 24:1493-1497.
3. Brack-Werner R. Astrocytes. HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999, 13:1-22.
4. Ranki A, Nyberg M, Ovod V, et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995, 9:1001-1008.
5. Saito Y, Sharer LR, Epstein LG, et al. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatrie central nervous tissues. Neurology 1994, 44:474-481.
6. Tornatore C, Meyers K, Atwood W, Conant K, Major E. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 1994, 68:93-102.
7. Budka H, Costanzi G, Cristina S, et aJ. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Ada Neumpathol (Berlin) 1987, 75:185-198.
8. Gray F, Scaravilli F, Everall I, et al. Neuropalhology of early HIV-1 infection. Brain Palhol 1996, 6:1-15.
9. He J, DeCastro CM, Vandenbark GR, Busciglio J, Gabuzda D. Astrocyte apoptosis induced by HIV-1 transactivation of the ckit protooncogene. Proc Natl Acad Sei USA 1997, 94:3954-3959.
10. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am l Palhol 1995, 146:1121 -1130.
11. Shi B, De Girolami U, He J, et al. Apoptosis induced by HIV-1 infection of the central nervous system. I Clin Invest 1996, 98:1979-1990.
12. Brack-Werner R, Kleinschmidt A, Ludvigsen A, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992, 6:273-285.
13. Joag SV, Stephens EB, Galbreath D, et al. Simian immunodeficiency virus SIVmac chimeric virus whose env gene was derived from SIV-encephalitic brain is macrophage-tropic but not neurovirulent. J Virol 1995, 69:1367-1369.
14. Neumann M, Felber BK, Kleinschmidt A, et al. Restriction of HIV-1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995, 69:2159-2167.
15. Ludwig E, Ceccherini-Silberstein F, van Empel J, Erfle V, Neumann M, Brack-Werner R. Diminished rev-mediated stimulation of HIV-1 protein synthesis is a hallmark of human astrocytes. J Virol 1999, 73:8279-8289.
16. Kleinschmidt A, Neumann M, Möller C, Erfle V, Brack-Werner R. Restricted expression for HIV-1 in human astrocytes. molecular basis for viral persistence in the CNS. Res Virol 1994, 145:147-153.
17. Saucier M, Hodge S, Devvhurst S, et al. The tyrosine-17 residue of Nef in SIVsmm PBJ14 is required for acute pathogenesis and contributed to replication in macrophages. Virology 1998, 244:261-272.
18. Du Z, Lang SM, Sasseville VC, et al. Identification of a nefallele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 1995, 82:665-674.
19. Baur AS, Sawai ET, Dazin P, FantI VVJ, Cheng-Mayer C, Peterlin BM. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994, 1:373-384.
20. Bachelerie F, Alcami J, Hazan U, et al. Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity. ; Virol 1990, 64:3059-3062.
21. Richard A, Robichaud C, Lapointe R, Bourgoin S, Darveau A, Poulin L. Interference of HIV-1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factoralpha in human glial cells. AIDS 1997, 11:F1-F7.
22. Romero IA, Teixeira A, Strosberg AD, Cazaubon S, Couraud PA. The HIV-1 nef protein inhibits extracellular signal-regulated kinase-dependent DNA synthesis in a human aslrocytic cell lineJfVeurochem 1998, 70:778-785.
23. Kohleisen B, Neumann M, Herrmann R, et al. Cellular localization of Nef expressed in persistently HIV-1 infected low producer astrocytes. AIDS 1992, 6:1427-1436.
24. Saksela K, Cheng G, Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of src kinases and are required for the enhanced growth of Nef+ viruses but not for downregulation of CD4. EMBO11995, 14:484-491.
25. Brack-Werner R, Görblich T, Werner T, et al. Sequence analysis of neuroinvasive and blood-derived HIV-1 nef-genes. In Proceedings of Technical Advances in AIDS Research in the human Nervous System. New York. Plenum Press; 1995: 189-204.
26. Morgenstern JP, Land H. Advanced mammalian gene transfer, high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Add Res. 1992, 18:3587-3596.
27. Kohleisen B, Caedigk-Nitschko K, Ohlmann M, et al. Heparinbinding capacity of the HIV-1 Nef-protein allows one-step purification and biochemical characterization. J Virol Methods 1996,60:89-101.
28. Ovod V, Lagerstedt A, Ranki A, et al. Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 1992, 6:25-34.
29. Meliert W, Kleinschmidt A, Schmidt J, et al. Infection of human fibroblasts and osteoblast-like cells with HIV-1. AIDS 1990, 4:527-535.
30. Hohenadl C, Germaier H, VValchner M, et al. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol 1999, 113:587-594.
31. Comez-Manzano C, Fueyo J, Kyritsis AP, et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized cell death of human glioma cells via apoptosis. Cancer Res 1996, 56:694-699.
32. Fueyo J, Gomez-Manzano C, Yung WKA, et al. Ovcrexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nature Med. 1998, 4:685-690.
33. Sanders VJ, Pittman CA, White MG, Wang G, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS 1998, 12:1021-1026.
34. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive aslrocytes. cellular and molecular cues to biological function. Trends K'eurascJ. 1997, 20:570-577.
35. Casque P, Singhrao SK, Neal JW, Coetze O, Morgan BP. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Palhol 1997, 150:31-41.
36. Smith ME, MacFarlin DE, Dhib-Jalbut S. Differential effect of interleukin-1 beta on la expression in astrocytes and microglia. J Neuroimmunol 1993, 46:97-104.
37. Weber F, Meinl E, Aloisi F, et al. Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 1994, 117:59-69.
38. Ulvestad E, Williams K, Bo L, Trapp B, Antel J, Mork J. HIA class II molecules (HIA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro. Immunology 1994, 82:535-541.
39. Flanders KC, Ren RF, Lippa CF. Transforming growth factorbetas in neurodegenerative disease. Prog Neurobiol 1998, 54:71-85.
40. Echarri A, Gonzales ME, Carrasco L The N-terminal Arg-rich region of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus Nef is involved in RNA binding. EurJ Biochem 1997, 246:38-44.
41. Niederman TMJ, Hastings WR, Ratner L. Myristoylationenhanced binding of the HIV-1 Nef protein to T-cell skeletal matrix. Virology 1993, 197:420-425.
42. Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten amino acid proline-rich SH3 binding site. Science 1993, 259:1157-1161.
43. Saksela K, Cheng C, Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of src kinases and are required for the enhanced growth of Nef + viruses but not for downregulation of CD4. EMBO J 1995, 14:484-491.
44. Mangasarian A, Trono D. The multifaceted role of HIV Nef. Res Virol 1997,148:30-33.
45. Luo T, Garcia JV. Regulation of Nef function. Res Virol 1997, 148:64-68.
46. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis. requirement for a critical dileucine motif in the membrane-proximal CD4 cyloplasmic domain. Cell 1994, 76:853-864.
47. Anderson S, Shugars DC, Swanstrom R, Garcia JV. Nef from primary isolates of humati immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol 1993, 67:4923-4931.
48. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature 1991, 350:508-511.
49. Creenway AL, McPhee DA, Grgacic E, et al. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus type 1 pNL4.3 downregulates surface CD4 and IL 2R expression in peripheral blood mononuclear cells and transformed T-cells. Virology 1994, 198:245-256.
50. Guy B, Kieny MP, Rivière Y, et al. HIV F/3′orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 1987, 330:260.
51. Harris M, Neil JC. Myristoylation-dependent binding of HIV-1 nef to CD4. l Mol Biol 1994, 241:136-142.
52. Craig HM, W. PM, Cuatelli JC. Interaction of HIV-1 nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl AcadSdUSA 1998, 95:11229-11234.
53. Greenberg W, DeTulleo L, Rapoport I, Skowronski J, Kirchhausen T. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. CurrBiol 1998, 8:1239-1242.
54. Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Celeziunas R, Greene WC. A dileucine motif in HIV-1 Nef acts as an inlernalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr Biol 1998, 8:1235-1238.
55. Hodge S, Novembre FJ, Dewhurst S. Endogenous tumor necrosisa factor-alpha contributes to lymphoproliferation induced by simian immunodeficiency variant, SIVsmm PBJ14. Immunol te 1998, 63:49-51.
56. Luo W, Peterlin BM. Activation of the T-cell receptorsignaling pathway by Nef from an aggressive strain of simian immunodeficiency virus. ; Virol 1997, 71:9531-9537.
57. Ahmad N, Venkatesan S. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 1988, 241:1481-1485.
58. Yu C, Felsted R. Effect of myristoylation on p27 Nef subcellular distribution and suppression of HIV-LTR transcription. Virology 1992, 187:46-55.
59. Maitra RK, Ahmad N, Holland SM, Venkatesan S. Human immunodeficiency virus type I (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines. Virology 1991, 182:522-533.
60. Spina CA, Kwoh TJ, Chowers MY, Cuatelli JC, Richman DD. The importance of nef in the induction of human immunodeficiency virus type 1 replication from quiescent CD4 lymphocytes. ; Exp Med 1994, 179:115-123.
61. Rhee SS, Marsh JVV. HIV-1 nef activity in murine T-cells. CD4 modulation and positive enhancement. J Immunol 1994, 152:5128-5134.
62. Miller MD, Warmerdam MT, Gaston I, Grcene WC, Feinberg MB. The human immunodeficiency virus-1 nef gene product. A positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994, 179:101-113.
63. Murphy KM, Sweet MJ, Ross IL, Hume DA. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HlV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. J Virol 1993, 67:6956-6964.
64. Briggs SD, Sharkey M, Stevenson M, Smithgall TE. SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. ; Biol Chem 1997, 272:17899-17902.
65. Yamanaka MK, Yilma T. Altered plaque formation by recombinant vaccinia virus expressing simian immunodeficiency virus Nef. 7 Virol 1998, 72:5291-5295.
66. Bodeus M, Marie-Cardine A, Bougeret C, Ramos-Morales F, Benarous F. In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. y Gen Virol 1995, 76:1337-1344.
67. Sawai ET, Baur AS, Peterlin BM, Levy JA, Cheng-Mayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. ; Biol Chem 1995, 270:15307-15314.
68. Hanna Z, Kay DC, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-Iike disease induced by HIV-1 in transgenic mice. Cell 1998, 95:163-175.
69. Ambrosini E, Slepko B, Kohleisen B, et aJ. Nef alters the expression of the ßll and ε isoforms of protein kinase C and the activation of the long terminal repeat promoter in human astrocytoma cells. Clia 1999, 27:143-151.
70. Minana R, Sancho-Tello M, Climent E, Segui JM, Renau-Piqueras J, Guerri C. Intracellular location, temporal expression, and polysialylation of neural cell adhesion molecule in astrocytes in primary culture. Glia 1998, 24:415-427.1.